PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Science. Author manuscript; available in PMC 2012 May 4.
Published in final edited form as:
PMCID: PMC3232424
NIHMSID: NIHMS337225

Exercise and Genetic Rescue of SCA1 via the Transcriptional Repressor Capicua*

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by expansion of a translated CAG repeat in Ataxin-1 (ATXN1). To determine the long-term effects of exercise, we implemented a mild exercise regimen in a mouse model of SCA1 and found a considerable improvement in survival accompanied by upregulation of epidermal growth factor and consequential downregulation of Capicua, an ATXN1 interactor. Offspring of Capicua mutant mice bred to SCA1 mice showed significant improvement of all disease phenotypes. Although polyglutamine-expanded Atxn1 caused some loss of Capicua function, further reducing Capicua levels, either genetically or by exercise, mitigated the disease phenotypes. Thus, exercise might have long-term beneficial effects in other ataxias and neurodegenerative diseases.

Spinocerebellar ataxia type 1 (SCA1) is characterized by a progressive loss of motor skills, usually beginning with impaired gait and balance (1). As with other neurodegenerative diseases, the disease protein ATAXIN-1 (ATXN1) is abundantly expressed in most neurons yet some neuronal populations are more vulnerable than others. In SCA1, cerebellar Purkinje cells are first to show dysfunction; eventually other neuronal populations, including deep cerebellar and brainstem nuclei, are affected, leading to premature death (2). While exercise has beneficial effects on many brain functions (3), it is not clear whether it would be protective in SCA1 or would accelerate neuronal demise by increasing the activity and metabolic demands on these already-vulnerable neuronal populations, as has been suggested for other neurodegenerative diseases (4, 5).

To determine the effects of exercise in SCA1, we implemented a mild exercise regimen in the Atxn1154Q knock-in mice, which bear 154 CAG repeats targeted into the endogenous mouse locus to create a model that recapitulates all aspects of SCA1 (6). From 4 to 8 weeks of age, wild-type (WT) or Atxn1154Q mice were placed on a fixed speed rotarod apparatus 5 times/week, while control mice were placed on an immobile rotarod apparatus. At 10 weeks of age we found no significant improvements in motor performance (Figure S1A and B), but Atxn1154Q mice that were exercised showed a remarkable and highly significant extension of lifespan of (Figure 1A).

Figure 1
Exercise extends lifespan in Atxn1154Q mice by upregulating EGF and consequently downregulating of Cic. (A) Median survival was 272 days for non-exercised Atxn1154Q mice vs 317 days for exercised Atxn1154Q mice (45 day extension, N = 6 per group, p <0.01 ...

To determine the molecular mechanism of this rescue, we measured the expression of several growth factors in vulnerable tissues (cerebellum and brainstem) one week after the last exercise session. We found a sustained increase in the level of epidermal growth factor (EGF) in the brainstem but not the cerebellum (Figure 1B and S1). Since Drosophila data indicate that Capicua (Cic) lies downstream of EGF signaling (7), and we previously showed that Cic interacts with Atxn1(8), we measured Cic levels after exercise and found a significant decrease in the brainstem (Figure 1C and D) but not the cerebellum (Figure S1B). Notably, exercise did not affect brainstem Atxn1154Q protein levels (Figure S1F). Additionally, primary brainstem neuronal cultures treated with recombinant EGF for 72 hours showed a dose-dependent decrease in Cic levels (Figure 1E). Thus, EGF regulates Cic levels in vivo and in vitro, and reduction of Cic might modulate the survival of Atxn1154Q mice.

To test formally the effect of reduced Cic levels on SCA1 phenotypes, we generated a loss-of-function allele of Cic and backcrossed these mice onto a C57BL/6 strain (Figure S2A). Two isoforms of Cic, long (Cic-L) and short (Cic-S), are transcribed from alternative promoters. Cic-L-/- mice completely lack the Cic-L isoform with ~10% of Cic-S remaining (Figure S2B). Importantly, Cic-L+/- mice had a ~50% reduction of both Cic-L and Cic-S. Cic protein is reduced in Atxn1-/- cerebellum (8), and we also found a Cic dose-dependent reduction of Atxn1 and its paralog Ataxin-1 Like (Atxn1L) in WT, Cic-L+/-, and Cic-L-/- cerebellum (Figure S2B), confirming the interdependency of Cic and Atxn1 paralog proteins in vivo.

To determine whether reducing the level of Cic would affect disease course in SCA1, we bred Atxn1154Q male mice to Cic-L+/- female mice to generate WT, Cic-L+/-, Atxn1154Q, and Atxn1154Q; Cic-L+/- mice, all on a pure C57BL/6 background. Because of their motor impairments, Atxn1154Q mice showed less total locomotor activity in the open field assay than WT, but Atxn1154Q; Cic-L+/- mice performed significantly better than their Atxn1154Q littermates (Figure 2A). Reduced Cic levels also significantly improved the motor coordination defects normally seen in Atxn1154Q mice (Figure 2B and C). Reduced Cic levels also improved the learning and memory deficits Atxn1154Q mice normally exhibit in the conditioned fear assay (Figure 2D). These improved phenotypes were accompanied by reduction in neuropathology: Atxn1154Q; Cic-L+/- mice had significantly more Purkinje cells than Atxn1154Q mice at 40 weeks of age (Figure 3A and B). Thus, a 50% reduction of Cic levels is enough to mitigate the behavioral defects and Purkinje cell loss in Atxn1154Q mice.

Figure 2
Reduction of Cic rescues multiple behaviors in SCA1 mice. Reduction of Cic by 50% in Atxn1154Q mice resulted in motor improvements in the open field assay (A), dowel test (B), rotarod (C), and conditioned fear assay of learning and memory (D). Legend ...
Figure 3
Reduction of Cic rescues multiple phenotypes in SCA1 mice. A 50% reduction of Cic in Atxn1154Q mice rescued Purkinje cell integrity (A and B, N = 4 per genotype), body weight (C), and premature lethality (D, p < 0.05 by log-rank test). The median ...

Reduction of Cic levels also improved phenotypes that could be attributed to other brain regions. Following weaning, Atxn1154Q mice lost weight progressively, but loss of one Cic allele was enough to significantly rescue this weight loss (Figure 3C). As with the exercised Atxn1154Q mice, the median age of survival of the Atxn1154Q; Cic-L+/- mice was significantly older than that of Atxn1154Q mice (Figure 3D). These data likely explain why exercise improved the longevity of Atxn1154Q mice but not the impaired coordination: exercise reduced Cic levels only in the brainstem and not in the cerebellum.

To determine the mechanism by which constitutive reduction of Cic rescues SCA1, we focused on the cerebellum, the primary site of dysfunction. We examined how the Atxn1154Q protein influenced the transcriptional repressor function of Cic by comparing microarrays of Cic-L-/- cerebella (Table S1) with previous microarrays from Atxn1154Q cerebellum (9). We identified many “hyper-repressed” genes (upregulated in Cic-L-/- but downregulated in Atxn1154Q), with >50% containing a Cic motif (10) (Table S2). We selected several of these hyper-repressed target genes and found that genes that were downregulated in Atxn1154Q cerebellum were in fact restored to near WT levels in Atxn1154Q; Cic-L+/- cerebellum, with significantly more Cic bound to their promoters in Atxn1154Q vs WT mice (Figure 4A). This suggests that the mechanism of disease rescue is relief of Cic hyper-repression conferred by polyglutamine-expanded Atxn1.

Figure 4
Atxn1154Q causes concomitant gain and loss of Cic transcriptional function. (A) Atxn1154Q hyper-repressed cerebellar transcripts containing a Cic motif, but these were normalized to near WT levels in Atxn1154Q; Cic-L+/- mice measured by RT-qPCR (mean ...

In Drosophila, overexpression of Atxn182Q is rescued by overexpression of Cic and is exacerbated by Cic reduction (8, 11). Although this is likely due to a titration of the endogenous Drosophila Cic away from its normal transcriptional targets, it suggests that polyglutamine-expanded Atxn1 could cause a loss of Cic transcriptional function (de-repression). We identified many “de-repressed” genes (upregulated in both Cic-L-/- and Atxn1154Q cerebella, Table S3), that were in fact even further upregulated in Atxn1154Q; Cic-L+/- cerebellum, with significantly less Cic bound to their promoters in Atxn1154Q vs WT mice (Figure 4B). This suggests that polyglutamine-expanded Atxn1 does indeed cause Cic to lose some transcriptional repressor activity, but this could not explain the genetic rescue; if partial loss of Cic activity was the driving factor in pathogenesis, the disease phenotype would be exacerbated in Atxn1154Q; Cic-L+/- mice. We propose that the polyglutamine-expanded Atxn1 causes Cic to bind more tightly to certain transcriptional targets (hyper-repressing them) while concomitantly causing Cic to bind less to, and thus upregulate (de-repress), other transcriptional targets. Genetic or exercise-induced reduction of Cic relieves the toxic hyper-repressive activity despite the concomitant loss of normal repressive function (Figure S3), consistent with the fact that the gain-of-function mechanism is the driving mechanism for toxicity in SCA1. While other polyglutamine diseases are caused by a gain-of-function mechanism despite partial loss of function of the involved protein (9, 1113), here we have demonstrated that polyglutamine-expanded protein can cause concomitant gain- and loss-of-function effects on the same native protein partner. The level of polyglutamine-expanded Atxn1 protein was reduced by ~9% in Atxn1154Q; Cic-L+/- mice compared to Atxn1154Q mice (Figure S2C and D), and while this could possibly contribute to the phenotypic rescue, we suggest that the rescue is more likely caused by relief of Cic-dependent hyper-repression. Therapeutics aimed at lowering Cic levels or disrupting the Cic-Atxn1154Q protein interaction could potentially ameliorate the disease.

The effect of exercise on lifespan was long lasting, well after its discontinuation, underscoring the potential value of exercise beyond motor improvements. Thus, SCA1 individuals might benefit from an exercise program early in disease course (14, 15). It is interesting to note that genetic reduction of Cic also increased the lifespan of Atxn1154Q mice (by 3.5 weeks), but the magnitude of the survival effect was greater (~ six weeks) in exercised Atxn1154Q mice. Thus, other pathways such as enhanced growth factor signaling are likely to contribute to the effect. We cannot rule out the possibility that more intense or longer duration exercise could cause a sustained EGF increase and Cic decrease in the cerebellum that could lead to motor improvements. The exercise regimen we chose was quite gentle; a more rigorous or sustained exercise paradigm that engages the cerebellum more intensely might reduce cerebellar Cic levels and improve cerebellar phenotypes. It is encouraging that exercise and the accompanying increase in neuronal activity and metabolic demands do not seem to exacerbate the disease process in vulnerable neuronal populations, which may be important in a variety of neurodegenerative disorders.

Supplementary Material

SOM

Acknowledgments

JDF and HYZ conceived of the study and designed experiments. JDF, CMB, ANC, and YG performed behavioral assays and provided input on analysis. JDF and JC-B performed molecular work and analysis. PY, HK, and CS analyzed microarray data. JDF and HYZ wrote the manuscript with input from JC-B, AF, and HTO. We are grateful to Gabriele Schuster for the generation of mutant mice and the members of the HYZ laboratory for comments and discussions on the manuscript. This research was supported by NIH grants NS27699, NS27699-20S1–ARRA and HD24064 (BCM-IDDRC) to HYZ; 1F32NS055545 to JDF; and NS022920 & NS045667 to HTO. HYZ is an investigator with the Howard Hughes Medical Institute.

Footnotes

*This manuscript has been accepted for publication in Science. This version has not undergone final editing. Please refer to the complete version of record at http://www.sciencemag.org/. The manuscript may not be reproduced or used in any manner that does not fall within the fair use provisions of the Copyright Act without the prior, written permission of AAAS.

References and notes

1. Orr HT, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993;4:221–226. [PubMed]
2. Zoghbi HY, Orr HT. Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1. Journal of Biological Chemistry. 2009;284:7425–7429. [PubMed]
3. Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 2007;30:464–472. [PubMed]
4. Chiò A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472–476. [PubMed]
5. Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle & Nerve. 2004;29:656–662. [PubMed]
6. Watase K, et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron. 2002;34:905–919. [PubMed]
7. Astigarraga S, et al. A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling. EMBO J. 2007;26:668–677. [PubMed]
8. Lam YC, et al. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell. 2006;127:1335–1347. [PubMed]
9. Crespo-Barreto J, Fryer JD, Shaw CA, Orr HT, Zoghbi HY. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis. PLoS Genet. 2010;6:e1001021. [PMC free article] [PubMed]
10. Kawamura-Saito M, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet. 2006;15:2125–2137. [PubMed]
11. Lim J, et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature. 2008;452:713–718. [PMC free article] [PubMed]
12. Thomas PS, Jr, et al. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum Mol Genet. 2006;15:2225–2238. [PubMed]
13. Van Raamsdonk JM, et al. Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum Mol Genet. 2005;14:1379–1392. [PubMed]
14. Vaz DV, et al. Treadmill training for ataxic patients: a single-subject experimental design. Clin Rehabil. 2008;22:234–241. [PubMed]
15. Ilg W, et al. Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology. 2009;73:1823–1830. [PubMed]